日本語 >>
TOP page
Educational Background
Work experience /Academic appointments
Publications
(Last updated : 2024-06-11 16:34:14)
NABEKA Hiroaki
Department
Matsuyama University School of Clinical Pharmacy, College of Pharmaceutical Sciences
Position
Professor
Educational Background
1.
2006/04~2010/03
〔Doctoral course〕, Graduate School, Division of Medical Sciences, Ehime University, Completed,
Work experience /Academic appointments
1.
2010/04~2018/03
Assistant Professor
Publications
1.
2024/06
Article
A peer-learning interprofessional learning program conducted through a joint class between Matsuyama University College of Pharmaceutical Sciences and Ehime University School of Medicine, towards a novel class dasign based on the newly revised Model Core Curricula for medical professionals in Japan (Collaboration)
2.
2023/12
Article
Neurotoxic stimulation alters prosaposin levels in the salivary systems of rats (Collaboration)
3.
2023/09
Article
Tracking of Prosaposin, a Saposin Precursor, in Rat Testis (Collaboration)
4.
2023/04
Article
Administration of prosaposin-derived neurotrophic factor to neural tube defects facilitates regeneration and restores neurological functions (Collaboration)
5.
2022/08
Article
A comprehensive design for prevention and management of COVID-19 in a tertiary medical institution in Bangladesh (Collaboration)
6.
2021/08
Article
The expression of prosaposin and its receptors, GRP37 and GPR37L1, are increased in the developing dorsal root ganglion (Collaboration)
7.
2021/06
Article
Inhibition of low-density lipoprotein uptake by Helicobacter pylori virulence factor CagA (Collaboration)
8.
2021/02
Article
Prosaposin, a neurotrophic factor, protects neurons against kainic acid-induced neurotoxicity (Single)
9.
2021
Article
Postmortem interval estimation by evaluating saposin D levels and morphological alterations in hippocampal neurons (Collaboration)
10.
2020/12
Article
Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19. (Collaboration)
11.
2020/12
Article
Prosaposin and Its Receptors, GRP37 and GPR37L1, Protects Neurons Against In Vivo Neuropathological Disorders (Collaboration)
12.
2020/12
Article
Reply to “Ivermectin Treatment May Improve the Prognosis of Patients with COVID-19” (Collaboration)
13.
2020/12
Article
Risk of congenital birth defects during COVID-19 pandemic: Draw attention to the physicians and policymakers. (Collaboration)
14.
2020/11
Article
Expression of the G protein-coupled receptor (GPR) 37 and GPR37L1 in the mouse digestive system. (Collaboration)
15.
2020/11
Article
Prosaposin in the rat oviductal epithelial cells. (Collaboration)
16.
2020/01
Article
Age- and sex-associated changes in prosaposin and its receptors in the lacrimal glands of rats. (Collaboration)
17.
2020
Article
Prosaposin and its receptors GRP37 and GPR37L1 show increased immunoreactivity in the facial nucleus following facial nerve transection. (Collaboration)
18.
2020
Article
Suppression of GABAergic transmission in the spinal dorsal horn induces pain-related behaviour in a chicken model of spina bifida. (Collaboration)
19.
2018/08
Article
Prosaposin and its receptors are differentially expressed in the salivary glands of male and female rats. (Collaboration)
20.
2017/12
Article
Early neonatal loss of inhibitory synaptic input to the spinal motor neurons confers spina bifida-like leg dysfunction in a chicken model. (Collaboration)
21.
2017/12
Article
Interneurons secrete prosaposin, a neurotrophic factor, to attenuate kainic acid-induced neurotoxicity. (Collaboration)
22.
2017/06
Article
Expression of prosaposin and its receptors in the rat cerebellum after kainic acid injection. (Collaboration)
23.
2016/06
Article
An 18-mer Peptide Derived from Prosaposin Ameliorates the Effects of Aβ1-42 Neurotoxicity on Hippocampal Neurogenesis and Memory Deficit in Mice. (Collaboration)
24.
2015
Article
A prosaposin-derived Peptide alleviates kainic Acid-induced brain injury. (Collaboration)
25.
2013
Book
Neural Tube Defects: Prevalence, Pathogenesis and Prevention (Collaboration)
Display 5 items
Display all(25)